Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function

Clinical trial NCT00076687 · COMPLETED

Trial details

NCT number: NCT00076687
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Stroke Muscle Spasticity Motor Neuron Disease

Start date: 2003-10-01
Primary completion: 2009-08-01
Enrollment: 155

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.